Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.
about
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge.Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey.Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasisRituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsThe compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder systemHepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation.Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyHigh Risk of Hepatitis B Reactivation among Patients with Acute Myeloid LeukemiaManagement of hepatitis B in developing countries.Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-AnalysisLong-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.Fulminant hepatitis following chemotherapy treatment for breast cancerA study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement.Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.Screening for viral hepatitis prior to rituximab chemotherapy.Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation.Hepatitis B reactivation after chemotherapy: two decades of clinical research.Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation.Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy.Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
P2860
Q33418708-3EBAC753-78F0-480B-832B-1053766BE635Q33619636-E554E1F8-6309-4B41-8C05-53DE110B5F01Q33782078-6A871455-717D-4CB9-90BF-941F53E044BEQ34037341-99F27CFB-AC98-4FAE-8B89-03DBF2CD4965Q34116912-9B761FAF-52B2-4AFB-8DA3-14D95AA04A02Q34394777-3C315724-9555-4F67-AA5A-5D43139AC841Q34786720-F6E8BA25-E0F8-4111-9332-C5A1C5F48090Q34854165-C8841D92-AA89-41B1-9FD5-B85054E5DF84Q35057889-D5F4D323-E414-4325-BDBD-F4CC49465ADEQ35210407-0D0DB8DB-5FEF-432F-833E-3FA23E3A59FDQ35597892-C5F84E7F-5814-4856-8047-DDEF70BA20B5Q35606765-DDA5FB4B-B588-4AB7-948C-841314A3D4E0Q35635637-162BA10B-F7DC-44BF-94BA-A3857FF5BAC6Q35658261-3498DE59-2EAA-4BE2-860F-0AA4E5FD648BQ36213915-4BF9B3FD-E9AB-48AB-BAC1-8681BEEF5AC5Q36406054-FB3EF417-64DE-4245-A922-21169EBF2640Q36654518-783574F3-F600-4A72-9E1A-E518D55722A7Q36704509-03DF33D3-B66A-48AD-B068-2E64F0D9C75CQ36756376-C8D6A5F9-818C-4603-A310-E636572F5421Q37150434-1345BBF2-3EC9-4465-9141-D88DD827C314Q37764963-A473F80D-451D-4657-BFF0-D0BD8CFAF353Q37820114-503AC00E-45A8-4501-BADD-9644EAD55A73Q37978202-97A02B6E-0CF5-4AFE-AB3C-5CC41F7A2354Q39034118-9E3442C2-8A4A-412C-90FD-3C8E1361BA7AQ39242000-11BCA402-0A22-4F21-9D02-CF5E7C08E99FQ40083609-12677777-7452-4961-845E-6307214527DEQ40633899-69022D01-53D0-4119-9AF3-23C780C3C116Q40993578-ED515CB1-3E41-48A0-BBE6-CCA12A926B14Q41756602-8D7F42A7-70E1-4389-878E-3A40A591572DQ42590960-C4E05FB4-A5AB-48A4-880A-A8E72ED63BF5Q43808456-085C6998-B4BF-4849-8ECD-2D2A0D44F175Q44218960-EE05F630-321D-498B-B030-87CF249A196BQ44242208-58C6DFF2-C865-4A23-BE2D-A9063E08ECD7Q45341296-F66F7788-BF6B-475C-A521-35F19BFD7DF0Q45366737-45ADAEAD-512F-44DA-B9F4-91F62344BDE4Q45419941-A3557973-B413-4F75-B08E-4388358D4B90Q47178355-E4F2BE35-AE1E-40A9-8DAD-6122F7187362
P2860
Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@ast
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@en
type
label
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@ast
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@en
prefLabel
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@ast
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@en
P2093
P1476
Chemotherapy and bone marrow t ...... iers: a review of the problem.
@en
P2093
P304
P356
10.1200/JCO.1999.17.1.394
P407
P577
1999-01-01T00:00:00Z